
[Today's headlines]
The American Industry Association sounded the alarm: the global circuit board shortage crisis is spreading
The global electronics industry is facing a severe shortage of printed circuit boards (PCBs). The Global Electronics Association (Global Electronics Association), headquartered in the United States, stated in an early warning report that such components are present in almost all consumer products containing electronic components, and the supply gap may have a broad impact on the global economy.
According to the industry group, printed circuit boards (PCBs) and related components are becoming increasingly difficult to procure. Currently, many companies in the automotive, medical, defense, aerospace and other industries are already facing supply delays or are preparing for delivery delays that may last weeks or even months. The announcement stated, “From fiberglass cloth and resin to finished circuit boards, demand for printed circuit boards at every step of the supply chain has exceeded supply capacity.”
“Although manufacturing capacity is expanding, particularly in Asia, what really limits supply is upstream, including glass fiber, resin, copper foil, and production equipment.”
The organization said the supply bottleneck will “continue until at least the first half of 2027,” and it is unlikely that the tight supply situation will substantively ease until mid-2028.
The PCB sector involves Hong Kong stocks: Jingwang Electronics (03228), Shenghong Technology (02476), Guanghe Technology (01989), Jiantao Laminate (01888), and Jiantao Group (00148)
[General outlook]
The three major US stock indices plummeted, and the “Big Seven Tech” declined across the board
Overnight, the Dow Jones Industrial Average fell 1101.11 points to close at 49097.06 points, or 2.19%; the S&P 500 stock index fell 147.8 points to close at 7175.83 points, or 2.02%; and the Nasdaq Composite Index fell 550.68 points, to close at 23879.2 points, or 2.25%.
The “Big Seven in Technology” declined across the board. Apple fell 0.92%, Microsoft fell 1.78%, Tesla fell 2.43%, Meta fell 3.27%, Nvidia fell 3.30%, Google-A fell 3.46%, and Amazon fell 3.87%; among them, Nvidia has been falling for the sixth consecutive trading day.
On the first day of listing, Anthropic's NASDAQ rose 17.07% from the issue price to 97.17 US dollars/share, with a market capitalization of 1.27 trillion US dollars. Shares of US new cloud and data center companies fell after Anthropic went public. CoreWeave fell 6.10%, IREN 5.45%, and Nebius 9.39%.
AMD plummeted by nearly 8%, and shorting agency Hunterbrook warned that it used a “circular transaction” similar to Nvidia. Dragged down by this, the semiconductor sector as a whole opened higher and lower. The Philadelphia Semiconductor Index fell 2.41%, while Micron Technology and Broadcom fell more than 2%.
Most Chinese securities fell, and e-commerce and content platforms were clearly divided. The Nasdaq China Golden Dragon Index fell 1.86% to 5193.02 points. In terms of individual stocks, Pinduoduo rose 11.04%, JD rose 2.89%, and Alibaba fell 1.26%. The Hang Seng Index ADR declined. On a proportional basis, it closed at 22640.88 points, down 200.74 points, or 0.88%, from the Hong Kong closing.
WTI crude oil futures on the New York Mercantile Exchange rose by 0.84 US dollars during the month to 83.15 US dollars per barrel, or 1.02%. COMEX gold futures fell $81.00 for the month's consecutive contracts, or 2.16%, to $3660.9 per ounce.
[Hot Topics Preview]
On the first day of listing, Anthropic closed up 17%, and its market capitalization once reached 1.5 trillion US dollars
Artificial intelligence company Anthropic (ANT) officially listed on NASDAQ with an issue price of $83 per share and an opening report of $111.5, up 34% from the issue price. Based on the opening price, the company's market capitalization is approximately $1.5 trillion. The IPO issued 980 million shares, with a total issuance of about US$81.34 billion, of which the company issued 956.35 million shares and old shareholders sold 23.6486 million shares. At the close, the company reported US$97.17 per share, up 17.1% from the issue price, and its market capitalization reached US$1.27 trillion.
Bank of China Gold Rental (01606) plans to purchase information technology computer equipment for 2,271 billion yuan
Bank of China Gold Rental (01606) announced that on November 19, 2026, the company (as the buyer) signed an equipment purchase agreement with Guangdong Shuhuan (as the seller). Based on this, the company agreed to purchase the subject of the procurement from Guangdong Shuhuan, at a total cost of approximately RMB 2,271 billion. The subject matter of the procurement consisted of approximately 1,200 information technology computer equipment.
The purchase of information technology computer equipment for rent is part of the Group's daily and general business. Transactions under the equipment purchase agreement help the company make full use of its financial advantages and experience in integrating industrial resources to further develop IT computer equipment and operating leasing business.
Hehuang Pharmaceutical (00013) announced that Silvec® (solepinib) has been approved by the China National Drug Administration for the treatment of primary immune thrombocytopenia and warm-antibody autoimmune hemolytic anemia
Hehuang Pharmaceutical (00013) announced that two new drug marketing applications for the novel, highly selective oral spleen tyrosine kinase (Syk) inhibitor SYVIK® (SYVIK®, solepinib/sovleplenib) were simultaneously approved by the China Drug Administration.
Alibaba-W (09988) net profit for the second quarter increased 207% year-on-year to 64.535 billion yuan
Alibaba-W (09988) released financial report for the second quarter of fiscal year 2027, with revenue of 271.52 billion yuan, up 10% year on year, estimated at 270.53 billion yuan; e-commerce group revenue of 197.24 billion yuan, up 2% year on year, estimated at 197.53 billion yuan; AI cloud and computing power service revenue of 60.97 billion yuan, up 53% year on year, estimated at 59.77 billion yuan; AI lab and application revenue of 4.44 billion yuan, up 51% year on year, estimated at RMB 27.71 billion; other revenue estimated at RMB 27.71 billion 688.2 billion yuan;
Alibaba's adjusted net profit for the second quarter was 19.01 billion yuan, up 92% year on year, estimated to be 26.61 billion yuan; adjusted revenue per ADS was 8.10 yuan, 4.36 yuan for the same period last year, estimated at 10.75 yuan; operating profit for the second quarter was 29.116 billion yuan, up 443% year on year; net profit attributable to common shareholders was 64.535 billion yuan, up 207% year on year.
Liberal Arts Interactive (00434) announced third quarter results. Profit attributable to shareholders of HK$800 million increased 206.9% year over year
Liberal Arts Interactive (00434) announced results for the third quarter ended September 30, 2026, with revenue of HK$128 million, a decrease of 0.2% year over year; gross profit of HK$94.41 million, up 0.1% year on year; profit attributable to shareholders of HK$800 million, up 206.9% year on year. The profit attributable to the owners of the Company was approximately HK$800 million, compared to about HK$261 million in the same period in 2025, an increase of 206.9% year-on-year, mainly due to the increase in the fair value of digital assets as of September 30, 2026 compared to the same period in 2025. The increase in other net earnings was mainly due to a significant increase in the fair value of digital assets held by the Group during the third quarter of 2026.
JD Health (06618) reached a strategic cooperation with Qilu Pharmaceutical to exclusively launch Kadasha®, a Class I innovative drug for lung cancer
On the day of signing the contract, Tongyuankang Pharmaceutical's self-developed and Qilu Pharmaceutical has exclusive commercial rights in mainland China, the Class I innovative drug Kadasha® (deuterosenitinib mesylate tablets) was exclusively launched on the JD Health Network. It further demonstrated the foundation of cooperation and synergy between the two sides in promoting innovative drugs and supplying high-quality pharmaceutical products.
Profit attributable to shareholders of Baisheng Group (03368) was 28.764 million yuan in the first three quarters, an increase of 23.02% year-on-year
Baisheng Group (03368) announced the results for the first three quarters ended September 30, 2026. The group achieved total operating revenue of about 2,528 billion yuan, a year-on-year decrease of 9.28%; profit attributable to the company owners was about 28.764 million yuan, an increase of 23.02% over the previous year; and same-store sales fell 11.6%. According to the announcement, the decrease in total operating revenue was mainly due to a decrease in self-operated sales and franchise sales commissions, and other revenue generated by lease revisions and termination.
CSPC Group (01093) received a development milestone payment of US$15 million under an exclusive licensing agreement with CORBUS PHARMACEUTICALS for CRB -701 (SYS 6002)
CSPC Group (01093) issued an announcement regarding the conclusion of an exclusive licensing agreement for CRB -701 (SYS 6002) with Corbus Pharmaceuticals Inc. (Corbus Pharmaceuticals), a subsidiary of the Company. Giant Rock Biotech received a $15 million development milestone payment from Corbus Pharmaceuticals on November 18, 2026. As of the date of this announcement, Jushi Biotech has received a total of US$32.5 million in down payments and development milestone payments from Corbus Pharmaceuticals under the agreement. The achievement of this milestone indicates that the relevant R&D work under the agreement is progressing steadily according to the plan.
NetEase (09999) achieved net profit of about 8.4 billion yuan in the third quarter, up 20.36% month-on-month, and “The Sixteen Voices of Yan Yun” surpassed 100 million users worldwide
NetEase (09999) announced its results for the third quarter of 2026, with net revenue of RMB 27.9 billion (US$4.2 billion) and gross profit of RMB 19 billion (US$2.8 billion), an increase of 4.8% over the previous year. Net profit attributable to the company's shareholders was RMB 8.4 billion (US$1.3 billion), up 20.36% month-on-month; net profit attributable to shareholders of the company under non-GAAP was RMB 9.2 billion (US$1.4 billion), up 18.29% month-on-month. Basic net profit per share was $0.39. The third quarter dividend was $0.117 per share.
In January-September, net revenue was about 88.55 billion yuan, up 4.08% year on year; gross profit of 61,479 billion yuan, up 12.37% year on year; net profit attributable to the company's shareholders was about 26.057 billion yuan.
Kuaishou-W (01024)'s operating profit for the first three quarters was 6.717 billion yuan. The average daily active users and average monthly active users of the Kuaishou app increased by 0.3% and 12.0% year-on-year, respectively
Kuaishou-W (01024) announced its results for the third quarter of 2026. The group obtained revenue of RMB 31,592 billion, gross profit of RMB 15.216 billion, adjusted net profit of RMB 790 million, and adjusted EBITDA of RMB 38.94 billion. In the first three quarters of 2026, the group obtained revenue of RMB 10.843 billion, gross profit of RMB 50.793 billion, operating profit of RMB 6.717 billion, profit for the period of RMB 5,098 billion, adjusted net profit of RMB 8077 billion, and adjusted EBITDA of RMB 17.246 billion.
[Individual stock prices are clear]
Lixun Precision (02475): Reports say that OpenAI's first AI end-side hardware was shipped at the end of the year, the company exclusively undertook the manufacture of the whole machine
On November 19, according to supply chain information from market media, OpenAI's first AI end-side hardware may start shipping at the end of 2026. Lixun Precision will exclusively undertake the manufacture of the complete machine and supply core components at the same time. A number of Chinese manufacturers are participating in the project.
The report points out that this is currently confirmed information about the closest mass production point for this product. At the beginning of this year, there were reports that the OEM order for OpenAI's first AI hardware might be transferred from Lixun Precision to Hon Hai and manufactured in a Vietnamese factory. Lixun Precision later clarified the rumor.